Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, PK, and PD of Bentracimab (PB2452) with Ticagrelor in Healthy Subjects
NCT03928353Phase 2Completed
- Sponsor
- SFJ Pharmaceuticals
- Start
- Apr 2019
- Primary completion
- Oct 2019
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of bentracimab in hemorrhage, sponsored by SFJ Pharmaceuticals. Started Apr 2019; status: completed.
02
Drugs
bentracimab
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT03928353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03928353.